Search research articles
Contact Us
Filters
Showing results (81-90 of 110) with videos related to
Page
of 11
Sort By:
European Journal of Medicinal Chemistry
|
May 16, 2025
Acyclic purine and pyrimidine nucleotide analogs as ecto-5'-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Brehova, et al.
Acta Pharmaceutica Sinica. B
|
May 27, 2024
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics
Rabea Voget, Julian Breidenbach, Tobias Claff, et al.
The Journal of Biological Chemistry
|
May 22, 2021
Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling
Joshua D Frenster, Gabriele Stephan, Niklas Ravn-Boess, et al.
Communications Chemistry
|
June 1, 2023
Crystal structure of adenosine A<sub>2A</sub> receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction
Tobias Claff, Jonathan G Schlegel, Jan H Voss, et al.
Journal of Medicinal Chemistry
|
July 7, 2015
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors
Sanjay Bhattarai, Marianne Freundlieb, Jan Pippel, et al.
Journal of Medicinal Chemistry
|
February 12, 2020
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes
Sanjay Bhattarai, Jan Pippel, Emma Scaletti, et al.
Journal of Medicinal Chemistry
|
May 16, 2024
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
Julian Breidenbach, Rabea Voget, Yaoyao Si, et al.
Journal of Medicinal Chemistry
|
August 15, 2024
Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity
Angelo Oneto, Ghazl Al Hamwi, Laura Schäkel, et al.
Nature Communications
|
April 5, 2023
Structure and function of the metagenomic plastic-degrading polyester hydrolase PHL7 bound to its product
P Konstantin Richter, Paula Blázquez-Sánchez, Ziyue Zhao, et al.
Journal of Medicinal Chemistry
|
November 22, 2023
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
Shenghua Gao, Letian Song, Katharina Sylvester, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 110) with videos related to
Sort By:
Page
of 11
European Journal of Medicinal Chemistry
|
May 16, 2025
Acyclic purine and pyrimidine nucleotide analogs as ecto-5'-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Brehova, et al.
Acta Pharmaceutica Sinica. B
|
May 27, 2024
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics
Rabea Voget, Julian Breidenbach, Tobias Claff, et al.
The Journal of Biological Chemistry
|
May 22, 2021
Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling
Joshua D Frenster, Gabriele Stephan, Niklas Ravn-Boess, et al.
Communications Chemistry
|
June 1, 2023
Crystal structure of adenosine A<sub>2A</sub> receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction
Tobias Claff, Jonathan G Schlegel, Jan H Voss, et al.
Journal of Medicinal Chemistry
|
July 7, 2015
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors
Sanjay Bhattarai, Marianne Freundlieb, Jan Pippel, et al.
Journal of Medicinal Chemistry
|
February 12, 2020
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes
Sanjay Bhattarai, Jan Pippel, Emma Scaletti, et al.
Journal of Medicinal Chemistry
|
May 16, 2024
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
Julian Breidenbach, Rabea Voget, Yaoyao Si, et al.
Journal of Medicinal Chemistry
|
August 15, 2024
Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity
Angelo Oneto, Ghazl Al Hamwi, Laura Schäkel, et al.
Nature Communications
|
April 5, 2023
Structure and function of the metagenomic plastic-degrading polyester hydrolase PHL7 bound to its product
P Konstantin Richter, Paula Blázquez-Sánchez, Ziyue Zhao, et al.
Journal of Medicinal Chemistry
|
November 22, 2023
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
Shenghua Gao, Letian Song, Katharina Sylvester, et al.
Page
of 11